World Health Organization Raises Warning Over Acute Scarcity of Weight-Loss Medications

Fewer than 10% of individuals eligible to benefit from obesity jabs like Wegovy are able to get them, states the World Health Organization as it issues its first guidance on the medications.

Given more than one billion people worldwide now classified as obese, it is advocating for increased and just access to GLP-1 medication.

Based on forecasts, more than two billion will be living with obesity by 2030 unless action is taken.

"The latest guidelines acknowledges that excess weight is a lifelong illness that can be addressed with thorough and continuous support," stated WHO director-general Tedros Adhanom Ghebreyesus.

Significant expense, insufficient output, and supply-chain constraints are significant barriers to widespread availability to the injections that can assist patients in reducing significant weight, notes the body.

Skinny Jab Scarcity

Even in the present most optimistic outlook, the supply of GLP-1 therapies would only suffice for about 100 million people – fewer than 10% of the global need, according to the WHO.

The recommendation calls on countries and companies to expand availability, through approaches like voluntary licensing.

The intellectual property rights on a key compound – the core ingredient of Novo Nordisk's Wegovy – is set to lapse in multiple nations in 2026.

How Obesity Injections Operate

These medications imitate a biological compound to slow digestion, curb appetite and boost the sense of being full so users consume fewer calories.

Individuals usually start to lose weight within a few weeks of commencing the regular doses.

Research suggests patients may regain a significant portion after a year of discontinuing the treatment, when their typical food cravings return.

To be above a healthy weight raises your likelihood for experiencing medical conditions, such as type 2 diabetes, heart disease, brain attack, and some cancers.

Excess weight impacts individuals in every country and was responsible for millions of deaths worldwide in 2024, per the health agency.

Brian Morris
Brian Morris

A tech enthusiast and digital strategist with over a decade of experience in software development and emerging technologies.